DexCom (DXCM) Research Hub

DexCom (DXCM) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 78.57 USD (+0.81%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 29.76, market cap 27.85B. This hub links to the full technical, earnings and options research available for DXCM.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNASDAQ, US
Last close78.57 USD (+0.81%)
52-week range67.3 USD – 92.56 USD
Trend regimeRange
14-day RSI38.1 (Bearish)
Trailing P/E29.76
Market cap27.85B
Dividend yield0.00%
Next earnings2026-07-30

Available research for DXCM

Earnings

DXCM earnings date and last-quarter result: next report 2026-07-30, last quarter beat, P/E 29.76. Updated 2026-07-23.

Options: Covered Call

Covered Call on DXCM: how it works, illustrative setup around the real 78.57 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on DXCM: how it works, illustrative setup around the real 78.57 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on DXCM: how it works, illustrative setup around the real 78.57 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

DXCM technical analysis: range, last 78.57 USD, RSI 38.1, 52w range 67.3 USD–92.56 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is DXCM in?

DexCom (DXCM) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.

Is DXCM in an uptrend or downtrend?

As of 2026-10-26, DXCM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is DXCM's trailing P/E ratio?

DXCM's trailing P/E is 29.76, with a market cap of 27.85B. See the earnings research page for full valuation detail.

When does DXCM next report earnings?

DXCM is next scheduled to report earnings on 2026-07-30.